EDSS
Showing 1 - 25 of 988
Multiple Sclerosis (MS) Trial in Basel, Luzern 16, Rheinfelden (Neurostatus-SMARTCARE, Standard Neurostatus-EDSS)
Recruiting
- Multiple Sclerosis (MS)
- Neurostatus-SMARTCARE
- Standard Neurostatus-EDSS
-
Basel, Switzerland
- +2 more
Jan 2, 2023
Automated EDSS Score Calculation by Smartphone Application
Completed
- MS CHRONIC PROGRESSIVE
- neurological exam
-
Nice, FranceNice University Hospital
Mar 17, 2022
Multiple Sclerosis, Iyenagar Yoga, Yoga, EDSS Trial in Prague (The effect of Iyengar yoga practice on patients with multiple
Active, not recruiting
- Multiple Sclerosis, Iyenagar Yoga, Yoga, EDSS
- The effect of Iyengar yoga practice on patients with multiple sclerosis
-
Prague, Czech Republic, CzechiaUniversity Hospital Motol
Mar 14, 2022
Multiple Sclerosis Trial in Vienna (EDSS, Discussion of symptoms, Patient reported outcome (MSIS))
Completed
- Multiple Sclerosis
- EDSS
- Discussion of symptoms, Patient reported outcome (MSIS)
-
Vienna, AustriaMedical University of Vienna
Jan 19, 2022
Multiple Sclerosis, Relapsing-Remitting Trial in Washington (NeuroQuant, Automated Neuropsychological Assessment Matrices, EDSS)
Completed
- Multiple Sclerosis, Relapsing-Remitting
- NeuroQuant
- +3 more
-
Washington, District of ColumbiaThe George Washignton University
Jan 4, 2023
Gestational Diabetes (GDM), Pregnancy Induced Hypertension (PIH), Anemia Trial in India, Nepal (mHealth Integrated Model of
Not yet recruiting
- Gestational Diabetes Mellitus (GDM)
- +2 more
- mHealth Integrated Model of Antenatal Care
-
Medak, Telangana, India
- +5 more
Jun 10, 2022
Multiple Sclerosis Study
Recruiting
- Multiple Sclerosis
- +2 more
-
Ljubljana, Osrednjeslovenska, Slovenia
- +3 more
Jun 16, 2022
CogMS - A Real-world Study Into Cognitive Impairment in People
Recruiting
- Multiple Sclerosis
- Custom study version of icompanion app
-
Fort Collins, Colorado
- +8 more
Jan 31, 2023
Observational Study on Multiple Sclerosis
Completed
- Multiple Sclerosis
- neurological examination, Kurtzke EDSS, Barthel scale, ecocolor-Doppler
- +2 more
- (no location specified)
Oct 18, 2019
Neuromyelitis Optica Spectrum Disorders, Pain Trial in Guangzhou (electroacupuncture)
Completed
- Neuromyelitis Optica Spectrum Disorders
- Pain
- electroacupuncture
-
Guangzhou, Guangdong, ChinaGuangdong Provincial Hospital of Chinese Medicine
May 20, 2023
Multiple Sclerosis Trial in Worldwide (MSCopilot® mobile application)
Not yet recruiting
- Multiple Sclerosis
- MSCopilot® mobile application
-
Oklahoma City, Oklahoma
- +6 more
Apr 3, 2023
Brain Abnormalities in Multiple Sclerosis.
Recruiting
- Multiple Sclerosis
- Dimethyl Fumarate 240 MG [Tecfidera]
-
Messina, ItalyIRCCS Centro Neurolesi "Bonino-Pulejo"
Mar 31, 2023
Elevated Factor VIII Related Labs asBiomarker for Incomplete
Not yet recruiting
- Multiple Sclerosis, Relapsing-Remitting
- blood tests drawn days 1, 8, 22 and 90 of the study
- (no location specified)
Jun 22, 2023
s in Patients With Relapsing Multiple Sclerosis
Recruiting
- Relapsing Multiple Sclerosis
- ofatumumab
- +2 more
-
Untermeiting, Bayern, Germany
- +35 more
Aug 12, 2022
OCT and Early Cognitive Impairment in Multiple Sclerosis
Completed
- Multiple Sclerosis
- OCT
-
Mansoura, Dakahlia, EgyptMansoura University Hospital
Nov 9, 2019
Fatigue, Functionality, Multiple Sclerosis Trial in Denizli (Nine-Hole Peg Test (NHPT))
Completed
- Fatigue
- +3 more
- Nine-Hole Peg Test (NHPT)
-
Denizli, TurkeyPamukkale Unıversity
May 25, 2023
Multiple Sclerosis Trial in La Laguna (Dry needling)
Completed
- Multiple Sclerosis
- Dry needling
-
La Laguna, Santa Cruz De Tenerife, SpainHospital Universitario de Canarias
Apr 27, 2022
MS Patients Treated With Sphingosine-1-phosphate Receptor
Recruiting
- Multiple Sclerosis
- S1PR analysis on immune cells
-
Bern, SwitzerlandNeurology department
Apr 12, 2023
Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Australia, Canada, United States
Active, not recruiting
- Primary Progressive Multiple Sclerosis
- Secondary Progressive Multiple Sclerosis
- ATA188
- Placebo
-
La Jolla, California
- +33 more
Jul 21, 2022
Microglia in the Pathogenesis of Progressive Multiple Sclerosis
Active, not recruiting
- Multiple Sclerosis
-
Turku, Finland Proper, FinlandTurku PET Centre
Oct 12, 2022
Inebilizumab and Rituximab in Neuromyelitis Optica Spectrum
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorders
- (no location specified)
Sep 29, 2023
Efgartigimod in Acute Neuromyelitis Optica Spectrum Disorders
Not yet recruiting
- Neuromyelitis Optica
- Efgartigimod
- Intravenous methylprednisolone (IVMP) and Efgartigimod
- IVMP
- (no location specified)
Nov 1, 2023
Relapsing-Remitting Multiple Sclerosis Trial in Hamburg, Mannheim (Autologous Hematopoietic Stem Cell Transplantation,
Terminated
- Relapsing-Remitting Multiple Sclerosis
- Autologous Hematopoietic Stem Cell Transplantation
- +2 more
-
Hamburg, Germany
- +1 more
Mar 1, 2022
Inebilizumab in Acute Neuromyelitis Optica Spectrum Disorders
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorder
- Inebilizumab
- oral immunosuppressant
- (no location specified)
Jun 5, 2023
Kesimpta® Treatment Effects in Relapsing Multiple Sclerosis
Recruiting
- Multiple Sclerosis
- Ofatumumab
-
Bamberg, Bavaria, Germany
- +21 more
Jan 25, 2023